Quality of End-of-Life Care for Children With Cancer
5 other identifiers
observational
2,425
1 country
28
Brief Summary
This study examines the role of access to care, patient/family interactions with the healthcare system, and stress in explaining variations in quality of end-of-life care. The data collected from this study may help researchers develop a model for identifying patients at risk of low-quality end-of-life care as well as recommendations for potential future interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
Longer than P75 for all trials
28 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2026
CompletedFirst Posted
Study publicly available on registry
February 17, 2026
CompletedStudy Start
First participant enrolled
July 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2031
September 4, 2026
September 1, 2026
4.5 years
February 4, 2026
September 3, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of end of life (EOL) care
Is a composite measure evaluated as the percent of applicable measures with high-quality care for each patient. For each child, will calculate the percent of measures applicable to that patient for which they met the criteria for high-quality care. Of note, not all measures will apply to every patient (e.g., assessment of sibling support will only apply to those with siblings). EOL quality will be treated as a continuous variable.
3 months to 2 years after the child's death
Study Arms (2)
Observational part 1
The medical records of deceased patients are reviewed on study.
Observational part 2
Bereaved parents complete a survey and may participate in an interview on study.
Interventions
Non-interventional study
Eligibility Criteria
Bereaved parents of an eligible deceased COG registered index child patient previously enrolled on Stratum 1 of APEC14B1, Project:EveryChild
You may qualify if:
- Index Child (COG Registered Patient):
- Must be deceased
- \< 18 years old at time of death
- Diagnosed with any oncologic condition
- History of enrollment on Stratum 1 of APEC14B1, Project:EveryChild
- Note: history of treatment on a COG therapeutic trial is not required
- Resided in the United States, including Puerto Rico, as evidenced by most recent address, at the time of death
- Bereaved Parent(s):
- Must be a parent, legal guardian, or caregiver (biological or non-biological) of an eligible Index Child enrolled on APEC14B1 with current Consent to Future Contact (e.g., from the APEC14B1 Part B Consent)
- Self-reported confirmation of familiarity with the care received by the Index Child in the last month of their life
- Bereaved parent must understand English or Spanish (written and/or spoken)
- Must be a parent/guardian/key contact from the Index Child's APEC14B1 Future Contact study record or must be referred by one of the APEC14B1 contacts
- Bereaved parent must be \>= 18 years old at the time of ALTE24C1 study enrollment
- Regulatory Requirements:
- Bereaved parent must provide verbal or implied informed consent
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (28)
Children's Hospital of Alabama
Birmingham, Alabama, 35233, United States
Arkansas Children's Hospital
Little Rock, Arkansas, 72202-3591, United States
Kaiser Permanente-Oakland
Oakland, California, 94611, United States
Alfred I duPont Hospital for Children
Wilmington, Delaware, 19803, United States
Golisano Children's Hospital of Southwest Florida
Fort Myers, Florida, 33908, United States
Memorial Regional Hospital/Joe DiMaggio Children's Hospital
Hollywood, Florida, 33021, United States
Nemours Children's Clinic-Jacksonville
Jacksonville, Florida, 32207, United States
Nemours Children's Hospital
Orlando, Florida, 32827, United States
Nemours Children's Clinic - Pensacola
Pensacola, Florida, 32504, United States
Children's Healthcare of Atlanta - Arthur M Blank Hospital
Atlanta, Georgia, 30329, United States
Augusta University Medical Center
Augusta, Georgia, 30912, United States
Blank Children's Hospital
Des Moines, Iowa, 50309, United States
Sinai Hospital of Baltimore
Baltimore, Maryland, 21215, United States
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
Grand Rapids, Michigan, 49503, United States
Bronson Methodist Hospital
Kalamazoo, Michigan, 49007, United States
Children's Mercy Hospitals and Clinics
Kansas City, Missouri, 64108, United States
Renown Regional Medical Center
Reno, Nevada, 89502, United States
Albany Medical Center
Albany, New York, 12208, United States
State University of New York Upstate Medical University
Syracuse, New York, 13210, United States
Montefiore Medical Center - Moses Campus
The Bronx, New York, 10467, United States
Rainbow Babies and Childrens Hospital
Cleveland, Ohio, 44106, United States
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania, 15224, United States
Rhode Island Hospital
Providence, Rhode Island, 02903, United States
Dell Children's Medical Center of Central Texas
Austin, Texas, 78723, United States
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas, 75390, United States
University of Virginia Cancer Center
Charlottesville, Virginia, 22908, United States
Providence Sacred Heart Medical Center and Children's Hospital
Spokane, Washington, 99204, United States
Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, 54301, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Emily E Johnston
Children's Oncology Group
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2026
First Posted
February 17, 2026
Study Start
July 31, 2026
Primary Completion (Estimated)
January 31, 2031
Study Completion (Estimated)
January 31, 2031
Last Updated
September 4, 2026
Record last verified: 2026-09